Cardiovascular Disease Risk in Women With Endometriosis

Description

To test the hypothesis that estrogen suppression impairs endothelial dysfunction in endometriosis.

Conditions

Endometriosis

Talk to us

Study Overview

On this page

Study Details

Study overview

To test the hypothesis that estrogen suppression impairs endothelial dysfunction in endometriosis.

Mechanisms and Interventions Addressing Accelerated Cardiovascular Disease Risk in Women With Endometriosis

Cardiovascular Disease Risk in Women With Endometriosis

Condition
Endometriosis
Intervention / Treatment

-

Contacts and Locations

New Haven

John B Pierce Laboratory, New Haven, Connecticut, United States, 06519

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Young women between the ages of 18 and 45 years (Controls);
  • * Young women between the ages of 18 and 45 years with endometriosis.
  • * Subjects who smoke
  • * Subjects who have diabetes,
  • * Subjects with sleep apnea or BP\>140/90 will be excluded.
  • * Women with endometriosis and severe acute pain requiring immediate treatment will be excluded.

Ages Eligible for Study

18 Years to 45 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Yale University,

Nina Stachenfeld, MD, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

2026-12-31